Viewing Study NCT02891551


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-04 @ 2:30 AM
Study NCT ID: NCT02891551
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2015-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands
Sponsor: Celgene
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NIPMS-VZ-NL-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators